Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,317.25
37.4 (1.64%)
BSENSE

Mar 24

BSE+NSE Vol: 52.27 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
1.64%
1.89%
1W
-4.78%
-2.63%
1M
-11.54%
-9.92%
YTD
-6.22%
-13.09%
1Y
-19.62%
-5.02%
3Y
79.61%
28.75%
5Y
65.34%
50.61%
10Y
25.81%
192.33%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.74%
0%
-6.74%
6 Months
-15.68%
0%
-15.68%
1 Year
-19.62%
0%
-19.62%
2 Years
18.02%
2.24%
20.26%
3 Years
79.61%
5.88%
85.49%
4 Years
49.97%
8.37%
58.34%
5 Years
65.34%
11.65%
76.99%

Latest dividend: 12 per share ex-dividend date: Nov-07-2024

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

4
Quartile
quartile-4
QTD
-7.73%
4
Quartile
quartile-4
Sep-Dec
-6.99%
4
Quartile
quartile-4
Jun-Sep
-21.48%
4
Quartile
quartile-4
1Y
-20.92%
2
Quartile
quartile-2
2025
9.98%
4
Quartile
quartile-4
2024
18.41%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
-7.73%
3
Quartile
quartile-3
Sep-Dec
-6.99%
4
Quartile
quartile-4
Jun-Sep
-21.48%
3
Quartile
quartile-3
1Y
-20.92%
1
Quartile
quartile-1
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the last 1 year and longer periods

2
Quartile
quartile-2
QTD
-7.73%
4
Quartile
quartile-4
Sep-Dec
-6.99%
4
Quartile
quartile-4
Jun-Sep
-21.48%
3
Quartile
quartile-3
1Y
-20.92%
2
Quartile
quartile-2
2025
9.98%
3
Quartile
quartile-3
2024
18.41%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available